News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
754,298 Results
Type
Article (54157)
Company Profile (289)
Press Release (699852)
Multimedia
Podcasts (76)
Webinars (13)
Section
Business (216139)
Career Advice (2889)
Deals (37367)
Drug Delivery (119)
Drug Development (86276)
Employer Resources (185)
FDA (17147)
Job Trends (15917)
News (367422)
Policy (35627)
Tag
Academia (2931)
Academic (1)
Accelerated approval (5)
Adcomms (27)
Allergies (93)
Alliances (52976)
ALS (98)
Alzheimer's disease (1478)
Antibody-drug conjugate (ADC) (143)
Approvals (17121)
Artificial intelligence (278)
Autoimmune disease (26)
Automation (16)
Bankruptcy (388)
Best Places to Work (12207)
BIOSECURE Act (20)
Biosimilars (116)
Biotechnology (206)
Bladder cancer (83)
Brain cancer (30)
Breast cancer (295)
Cancer (2379)
Cardiovascular disease (197)
Career advice (2426)
Career pathing (33)
CAR-T (167)
Cell therapy (459)
Cervical cancer (21)
Clinical research (69933)
Collaboration (880)
Compensation (536)
Complete response letters (26)
COVID-19 (2804)
CRISPR (47)
C-suite (262)
Cystic fibrosis (104)
Data (2254)
Decentralized trials (2)
Denatured (22)
Depression (53)
Diabetes (289)
Diagnostics (6741)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (129)
Drug pricing (118)
Drug shortages (30)
Duchenne muscular dystrophy (100)
Earnings (88752)
Editorial (43)
Employer branding (24)
Employer resources (158)
Events (119399)
Executive appointments (767)
FDA (18446)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (786)
Gene editing (115)
Generative AI (24)
Gene therapy (338)
GLP-1 (814)
Government (4882)
Grass and pollen (6)
Guidances (65)
Healthcare (20157)
Huntington's disease (24)
IgA nephropathy (30)
Immunology and inflammation (137)
Indications (30)
Infectious disease (2959)
Inflammatory bowel disease (151)
Inflation Reduction Act (9)
Influenza (54)
Intellectual property (100)
Interviews (560)
IPO (17006)
IRA (47)
Job creations (4135)
Job search strategy (2000)
Kidney cancer (11)
Labor market (38)
Layoffs (521)
Leadership (23)
Legal (8781)
Liver cancer (81)
Lung cancer (340)
Lymphoma (156)
Machine learning (7)
Management (62)
Manufacturing (325)
MASH (74)
Medical device (14061)
Medtech (14066)
Mergers & acquisitions (20903)
Metabolic disorders (753)
Multiple sclerosis (86)
NASH (23)
Neurodegenerative disease (107)
Neuropsychiatric disorders (32)
Neuroscience (2067)
NextGen: Class of 2025 (7147)
Non-profit (4915)
Now hiring (39)
Obesity (404)
Opinion (255)
Ovarian cancer (77)
Pain (96)
Pancreatic cancer (86)
Parkinson's disease (158)
Partnered (21)
Patents (244)
Patient recruitment (115)
Peanut (51)
People (62201)
Pharmaceutical (69)
Pharmacy benefit managers (20)
Phase I (21705)
Phase II (30657)
Phase III (22961)
Pipeline (1239)
Policy (159)
Postmarket research (2945)
Preclinical (9321)
Press Release (71)
Prostate cancer (111)
Psychedelics (38)
Radiopharmaceuticals (256)
Rare diseases (415)
Real estate (6458)
Recruiting (73)
Regulatory (24217)
Reports (48)
Research institute (2579)
Resumes & cover letters (456)
Rett syndrome (5)
RNA editing (5)
RSV (48)
Schizophrenia (79)
Series A (137)
Series B (89)
Service/supplier (14)
Sickle cell disease (58)
Special edition (17)
Spinal muscular atrophy (159)
Sponsored (32)
Startups (3881)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (43)
The Weekly (52)
Vaccines (778)
Venture capitalists (42)
Weight loss (281)
Women's health (36)
Worklife (19)
Date
Today (208)
Last 7 days (925)
Last 30 days (2763)
Last 365 days (34252)
2025 (11167)
2024 (36706)
2023 (41643)
2022 (52872)
2021 (57578)
2020 (56494)
2019 (49768)
2018 (37673)
2017 (34551)
2016 (34485)
2015 (40528)
2014 (34459)
2013 (29885)
2012 (31934)
2011 (32513)
2010 (30634)
Location
Africa (931)
Alabama (54)
Alaska (7)
Arizona (242)
Arkansas (14)
Asia (42780)
Australia (7770)
California (6245)
Canada (2039)
China (549)
Colorado (274)
Connecticut (281)
Delaware (153)
Europe (95782)
Florida (924)
Georgia (217)
Idaho (61)
Illinois (578)
India (27)
Indiana (322)
Iowa (11)
Japan (166)
Kansas (106)
Kentucky (25)
Louisiana (10)
Maine (62)
Maryland (935)
Massachusetts (4702)
Michigan (227)
Minnesota (410)
Mississippi (2)
Missouri (89)
Montana (29)
Nebraska (25)
Nevada (63)
New Hampshire (67)
New Jersey (1761)
New Mexico (30)
New York (1785)
North Carolina (1053)
North Dakota (8)
Northern California (2724)
Ohio (207)
Oklahoma (14)
Oregon (37)
Pennsylvania (1400)
Puerto Rico (13)
Rhode Island (35)
South America (1312)
South Carolina (24)
South Dakota (1)
Southern California (2342)
Tennessee (104)
Texas (922)
United States (23803)
Utah (185)
Virginia (152)
Washington D.C. (66)
Washington State (573)
West Virginia (3)
Wisconsin (56)
754,298 Results for "novanta inc formerly known as gsi group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2024
February 25, 2025
·
19 min read
Genetown
Novanta to Present at the CJS Securities 24th Annual New Ideas Summer Conference on Wednesday, July 10, 2024
Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at the CJS Securities 24th Annual New Ideas Summer Conference on Wednesday, July 10, 2024, in White Plains, New York.
June 18, 2024
·
1 min read
Press Releases
Identiv and Novanta Announce Strategic Partnership to Streamline Adoption of RFID Solutions for Healthcare OEMs
February 28, 2025
·
3 min read
Deals
Novanta completes acquisition of Motion Solutions
Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has completed the acquisition of Motion Solutions.
January 2, 2024
·
7 min read
Genetown
Novanta to Present at Baird’s 2024 Global Consumer, Technology & Services Conference on Wednesday, June 5, 2024
Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Baird’s 2024 Global Consumer, Technology & Services Conference on Wednesday, June 5, 2024, in New York, NY.
May 1, 2024
·
1 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Genetown
Novanta to Present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024
Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024, in Chicago, IL.
April 19, 2024
·
1 min read
Business
Novanta Announces Financial Results for the First Quarter 2024
Novanta Inc., a trusted technology partner to medical and advanced technology equipment manufacturers, reported financial results for the first quarter 2024.
May 7, 2024
·
27 min read
Business
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2023
Novanta Inc. today reported financial results for the fourth quarter and full year 2023.
February 28, 2024
·
34 min read
Business
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 7, 2023
Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2023 results on Tuesday, November 7, 2023.
October 10, 2023
·
1 min read
1 of 75,430
Next
